


A: Immobilized Human GPC3 / Glypican-3, His Tag at 2 μg/mL can bind Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab), EC50=0.003621μg/mL.
B:Immobilized Human GPC3 / Glypican-3(S495A, S509A), Fc Tag at 2 μg/mL can bind Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab), EC50=0.05101 μg/mL.


A: Huh-7 cells were stained with anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS.
B:HEP3B cells were stained with anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS.


A:The endocytosis ratio codrituzumab by HuH-7 increased with the increase of antibody concentration, and the Internalization Rate (%) reached 40%at antibody concentration of 1 nM.
B:Anti-GPC3 / Glypican-3 Reference Antibody (Codrituzumab) induced ADCC activity was evaluated using human GPC3 CHOS Cell. The max Lysis rate was approximately 30%.


A:Human GPC3 / Glypican-3 CHO Cell Line were stained with Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS.
B:Human GPC3 / Glypican-3 HEK293 Cell Line were stained with Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS.